Clinical Trials Logo

Filter by:
NCT ID: NCT03029416 Withdrawn - Cancer Clinical Trials

Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension

Start date: October 26, 2017
Phase: Phase 2
Study type: Interventional

30 Gy single fraction of SBRT for lung metastases will result in comparable oncologic outcomes to 18Gy in three fractions (or dosing to a BED </-100Gy at the discretion of the radiation oncologist) with respect to disease control and toxicity.

NCT ID: NCT03028753 Withdrawn - Clinical trials for Pelvic Floor Disorders

Accuracy of Bladder Scanners in Post-operative Voiding Trials

Start date: August 2016
Phase: N/A
Study type: Interventional

The investigators are trying to determine if using a bladder scanner (type of ultrasound) to check how much urine is left in the bladder is the same as checking that volume with a catheter (tube that goes into your bladder to drain urine). After urogynecologic surgery, the investigators perform a voiding trial. Water is put into the participant's bladder through the catheter (tube draining your bladder). The catheter is then removed and the participant is asked to empty their bladder. After that, the investigators will use the bladder scanner (ultrasound) to see how much urine is left in the participant's bladder. After the ultrasound, the investigators will pass a very small catheter (tube) into the bladder to take out the remaining urine. The investigators will then compare the amount obtained from the catheter to the ultrasound amount. This will also help the investigators to figure out if they need to check how much urine is left in a patient's bladder after the voiding trial.

NCT ID: NCT03028571 Withdrawn - Insulin Resistance Clinical Trials

Autonomic Blockade and Endogenous Glucose Production

Start date: April 17, 2017
Phase: Phase 1
Study type: Interventional

The investigators will test the null hypothesis that there will be no changes in the insulin-mediated suppression of endogenous glucose production (EGP) in response to autonomic blockade. To test this hypothesis, the investigators propose to determine the role of the autonomic nervous system in hepatic insulin resistance.

NCT ID: NCT03027401 Withdrawn - Neoplasms Clinical Trials

Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics

Start date: January 10, 2017
Phase:
Study type: Observational

Background: Saliva, blood, tissue, and cancer contain DNA. DNA makes the "instruction book" for the cells in the body. Cancer is caused by changes in DNA that affect cell function. Researchers want to test DNA of people with tumors. They want to look for genetic changes in tumors that could be targets for treatment. Because DNA can change as cancer changes, more testing may be done at different times. Objectives: To find the DNA changes in cancer that may help guide treatment. To collect samples and data to be used in future studies. Eligibility: People any age with cancer or a pre-cancerous tumor Design: - Participants will be screened with a medical history, physical exam, and blood tests. Participants will give a sample of their tumor. This is usually from a previous procedure. Participants will give a saliva or blood sample. They cannot eat, drink, smoke, or chew gum for 30 minutes before giving saliva. They will spit about 1 teaspoon of saliva into a tube. - Some participants may have a punch biopsy instead. A small instrument will take a small piece of skin. - Researchers will collect data from participants medical records. - Participants will answer questions about their family health history. They will also answer questions about their views on the study, including possible unexpected results. - Extra blood or tissue samples may be taken at other times during the participants' treatment. All samples will be saved in secure ClinOmics freezers to be used in future studies. - Participants will be told by their doctors if any test results affect their health or their cancer treatment.

NCT ID: NCT03027323 Withdrawn - Hypotension Clinical Trials

Washington Study of AxoTrack-Guided Central Venous Cannulation

WASHCAN
Start date: February 10, 2017
Phase: N/A
Study type: Interventional

Undifferentiated hypotension is a medical emergency where a patient's blood pressure drops to critical levels due to several possible reasons. The medical staff treating the patient will need to find out the reason for your drop in blood pressure as soon as possible. When treating low blood pressure, the medical staff typically performs a procedure called central venous cannulation (CVC). CVC involves accessing a large vein (usually the subclavian under the collarbone) by inserting a needle into the vein. By doing this, the medical staff can measure the pressures in the patient's veins or give medicine to the patient while they are in the hospital. The purpose of this study is to compare the time needed to complete CVC using the AxoTrack device to CVC guided by landmarks on a patient's body. The investigators expect that there will be a maximum of 30 patients enrolled in this study.

NCT ID: NCT03027076 Withdrawn - Clinical trials for Interstitial Cystitis

Microbiome of Urologic Chronic Pelvic Pain Syndrome

Start date: November 2013
Phase: N/A
Study type: Observational [Patient Registry]

This research is being done to learn more about the bacteria that live in the genito-urinary tract in subjects with urologic chronic pelvic pain syndrome (UCPPS).

NCT ID: NCT03026673 Withdrawn - Post Partum Pain Clinical Trials

Retrospective Review of NSAIDS in the Postpartum Period

Start date: January 18, 2017
Phase: N/A
Study type: Observational

Chart review of women who have delivered an infant in a single health care system to determine if NSAID use increases blood pressures in the postpartum period.

NCT ID: NCT03026647 Withdrawn - Clinical trials for Cesarean Section; Complications, Wound, Hematoma

Suture Material for Closure of Hysterotomy

Start date: January 31, 2017
Phase: N/A
Study type: Observational

Retrospective chart review evaluating different suture types on surgical outcomes for cesarean delivery and vaginal birth after cesarean delivery outcomes when different sutures are used.

NCT ID: NCT03026205 Withdrawn - Clinical trials for Viral Upper Respiratory Tract Infection

ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)

ARMS-I
Start date: January 2017
Phase: Phase 2
Study type: Interventional

This is a single center study to evaluate the pharmacokinetics of ARMS-I a formulation that incorporates cetylpyridinium chloride (CPC), administered once as a single dose of three sprays orally, followed by multiple dosing (3x daily oral sprays) over days 3-6 and then a repeat pharmacokinetic study during the final oral dose administered as the first dose on day 7 to ascertain CPC accumulation.

NCT ID: NCT03026023 Withdrawn - Hepatitis C Clinical Trials

Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant

Start date: August 1, 2018
Phase: Phase 4
Study type: Interventional

This is a proof of concept, single center study for the donation of HCV-positive hearts to HCV negative recipient patients, with preemptive, interventional treatment with 12-16 weeks of grazoprevir and elbasvir (with or without ribavirin) to prevent HCV transmission upon transplantation.